5AM Ventures’ Post

5AM Ventures reposted this

View organization page for Entrada Therapeutics, graphic

23,605 followers

Entrada Therapeutics announces $100 million registered direct offering. The offering was led by a U.S.-based healthcare focused investor, two global mutual funds and Janus Henderson Investors, a global asset management firm. Learn more here: https://lnkd.in/dDZpdq4d

  • A graphic with text that reads, “June 24, 2024” and “Entrada Therapeutics Announces $100 Million Registered Direct Offering”. Entrada’s logo is placed at the top right corner.
Darren Nelson 🚀 (We're hiring)

Innovative Leadership in Life Sciences & Technology Talent Solutions: Founder & CEO of Recruits Lab & BioJobs Lab, Driving Organizational Success through Cutting-Edge Recruitment Strategies

2mo

Congratulations on the $100 million registered direct offering! This is an impressive milestone for Entrada Therapeutics. Looking forward to seeing the positive impact this investment will have on your innovative healthcare initiatives.

Like
Reply
Xijun P.

mRNA Process Development and Manufacturing

1mo

Impressive growth!

Like
Reply
Henry Jin, PhD

Senior Director, Business Development @ KBI Biopharma | PhD, CMC Development

2mo

Congratulations!

Like
Reply
Mayur Shete

Bio-analytical Scientist II

2mo

Congratulations!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics